Cellectis
CLLS
#7199
Rank
NZ$0.85 B
Marketcap
NZ$8.19
Share price
-0.26%
Change (1 day)
143.99%
Change (1 year)

Cellectis (CLLS) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$0.16 Billion

According to Cellectis's latest financial reports the company's total debt is NZ$0.16 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Cellectis - Total debt on balance sheet (from 2008 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$0.16 B20.58%
2023-12-31NZ$0.13 B12.7%
2022-12-31NZ$0.11 B-19.19%
2021-12-31NZ$0.14 B-0.11%
2020-12-31NZ$0.14 B109.16%
2019-12-31NZ$70.68 M3409.68%
2018-12-31NZ$2.01 M4107.11%
2017-12-31NZ$0.04 M-98.12%
2016-12-31NZ$2.54 M-19.95%
2015-12-31NZ$3.17 M-44.52%
2014-12-31NZ$5.72 M-16.27%
2013-12-31NZ$6.83 M-1.19%
2012-12-31NZ$6.91 M-92.19%
2011-12-31NZ$88.51 M2219.17%
2010-12-31NZ$3.81 M56.16%
2009-12-31NZ$2.44 M-21.87%
2008-12-31NZ$3.12 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
uniQure
QURE
NZ$0.11 B-28.69%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
NZ$0.43 B 170.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$4.68 B 2,816.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA